FDA approves a new Alzheimer's drug from Eli Lilly

Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to know

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance

Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet it

Eli Lilly’s chief scientific officer on Covid antibody drug results

Jim Cramer: Eli Lilly stock represents real value

Eli Lilly CEO weighs in on Q4 revenue miss

Eli Lilly CEO David Ricks breaks down second-quarter earnings and drug pipeline